IL22 and pulmonary fibrosis: Moreover, in a SSc mouse model, a significant reduction of lung inflammation and pulmonary fibrosis was observed in the IL-22-deficient mice after they received high doses of bleomycin [92], indicating a pathogenic aspect of IL-22 in SSc.